	US 12,064,441 B2
	Composition for preventing or treating keloid
Yea Eun Kang, Daejeon (KR); Sang-Ha Oh, Daejeon (KR); Sunje Kim, Daejeon (KR); Seong Eun Lee, Daejeon (KR); Shinae Yi, Daejeon (KR); and Mi Ae Lim, Daejeon (KR)
Assigned to CHUNGNAM NATIONAL UNIVERSITY HOSPITAL, Daejeon (KR); and THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC), Daejeon (KR)
Filed by CHUNGNAM NATIONAL UNIVERSITY HOSPITAL, Daejeon (KR); and THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC), Daejeon (KR)
Filed on Aug. 9, 2022, as Appl. No. 17/818,378.
Claims priority of application No. 10-2021-0105047 (KR), filed on Aug. 10, 2021.
Prior Publication US 2023/0046998 A1, Feb. 16, 2023
Int. Cl. A61K 31/575 (2006.01); A61K 8/46 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61P 17/02 (2006.01)

CPC A61K 31/575 (2013.01) [A61K 8/466 (2013.01); A61K 9/0021 (2013.01); A61K 9/06 (2013.01); A61P 17/02 (2018.01)]

5 Claims

1. A method for improving keloids or preventing recurrence of keloids comprising administering to a subject in need thereof a composition comprising tauroursodeoxycholic acid as active ingredient, and thereby improving keloids or preventing recurrence of keloids in the subject.